Clinical Trial

A Study in Subjects With Neurogenic Orthostatic Hypotension

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).
Protocol Amendment History 6 changes
notable Primary completion pushed: 2026-07-31 -> 2026-09 2026-07-31
minor Completion pushed: 2026-08-31 -> 2026-10 2026-07-31
notable Primary completion pushed: 2026-05-31 -> 2026-07-31 2026-07-10
minor Completion pushed: 2026-06-30 -> 2026-08-31 2026-07-10
notable Primary completion pushed: 2026-03-31 -> 2026-05-31 2026-05-06
minor Completion pushed: 2026-03-31 -> 2026-06-30 2026-05-06
Trial Details
NCT Number NCT07089043
Lead Sponsor CuraSen Therapeutics, Inc.
Conditions Neurogenic Orthostatic Hypotension
Enrollment 12 participants
Start Date 2025-09-12
Primary Completion 2026-09 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-30